Insider · CIK 0001415297

Casey Mark J

Reports to the SEC for 4 companies · GAITHERSBURG, MD

sec.gov

Transactions

Companies

Filings

CIK

0001415297

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-03	NVAXNOVAVAX INCF Tax Payment	EVP, Chief Legal Officer	FTax Payment	−11.4K sh	$9.49	−$108K	90,067
2026-03-03	NVAXNOVAVAX INCM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+37.5K sh	—	—	101,445
2026-03-03	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−4,000 sh	—	—	4,000
2026-03-02	NVAXNOVAVAX INC · Restricted Stock UnitsA Award	EVP, Chief Legal Officer	AAward	+101K sh	—	—	101,000
2026-03-02	NVAXNOVAVAX INC · Non-Statutory Stock Option NQA Award	EVP, Chief Legal Officer	AAward	+152K sh	—	—	152,000
2026-03-02	NVAXNOVAVAX INC · Non-Statutory Stock Opotion NQA Award	EVP, Chief Legal Officer	AAward	+152K sh	$9.09	+$1.38M	152,000
2026-03-01	NVAXNOVAVAX INCM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+4,000 sh	—	—	65,159
2026-03-01	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−4,000 sh	—	—	4,000
2026-03-01	NVAXNOVAVAX INCF Tax Payment	EVP, Chief Legal Officer	FTax Payment	−1,214 sh	$10.14	−$12.3K	63,945
2025-12-11	NVAXNOVAVAX INCM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+41.9K sh	—	—	73,972
2025-12-11	NVAXNOVAVAX INCF Tax Payment	EVP, Chief Legal Officer	FTax Payment	−12.7K sh	$6.69	−$85K	61,159
2025-12-11	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−41.9K sh	—	—	41,899
2025-03-03	NVAXNOVAVAX INC · 2025 Non-statutory Stock Option NQA Award	EVP, Chief Legal Officer	AAward	+169K sh	$7.87	+$1.33M	169,000
2025-03-03	NVAXNOVAVAX INC · 2025 Restricted Stock Units RSUA Award	EVP, Chief Legal Officer	AAward	+113K sh	—	—	112,500
2025-03-01	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−4,000 sh	—	—	8,000
2025-03-01	NVAXNOVAVAX INCF Tax Payment	EVP, Chief Legal Officer	FTax Payment	−1,214 sh	$8.33	−$10.1K	31,973
2025-03-01	NVAXNOVAVAX INCM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+4,000 sh	—	—	33,187
2024-12-11	NVAXNOVAVAX INCF Tax Payment	EVP, Chief Legal Officer	FTax Payment	−12.7K sh	$8.82	−$112K	29,187
2024-12-11	NVAXNOVAVAX INCM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+41.9K sh	—	—	41,900
2024-12-11	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−41.9K sh	—	—	83,798
2024-03-01	NVAXNOVAVAX INC · Restricted Stock UnitsA Award	EVP, Chief Legal Officer	AAward	+12K sh	—	—	12,000
2023-12-11	NVAXNOVAVAX INC · Stock Options (Right to buy)A Award	EVP, Chief Legal Officer	AAward	+145K sh	—	—	144,694
2023-12-11	NVAXNOVAVAX INC · Restricted Stock UnitsA Award	EVP, Chief Legal Officer	AAward	+126K sh	—	—	125,698
2022-06-16	Keenova Therapeutics plcEmployee Share Options (Right to Buy)D Disposition to Issuer	EVP & Chief Legal Officer	DDisposition to Issuer	−39.6K sh	—	—	0
2022-06-16	Keenova Therapeutics plcEmployee Share Options (Right to Buy)D Disposition to Issuer	EVP & Chief Legal Officer	DDisposition to Issuer	−78.1K sh	—	—	0
2022-06-16	Keenova Therapeutics plcD Disposition to Issuer	EVP & Chief Legal Officer	DDisposition to Issuer	−32K sh	—	—	0
2022-06-16	Keenova Therapeutics plcEmployee Share Options (Right to Buy)D Disposition to Issuer	EVP & Chief Legal Officer	DDisposition to Issuer	−129K sh	—	—	0
2020-12-17	Keenova Therapeutics plcS Sale	EVP & Chief Legal Officer	SSale	−15.3K sh	$0.45	−$6,880.95	32,011
2020-04-02	Keenova Therapeutics plcF Tax Payment	EVP & Chief Legal Officer	FTax Payment	−2,110 sh	$1.80	−$3,798	47,302
2020-04-01	Keenova Therapeutics plcF Tax Payment	EVP & Chief Legal Officer	FTax Payment	−1,462 sh	$1.93	−$2,821.66	49,412
2020-02-01	Keenova Therapeutics plcF Tax Payment	EVP & Chief Legal Officer	FTax Payment	−1,252 sh	$4.59	−$5,746.68	50,874
2019-04-02	Keenova Therapeutics plcF Tax Payment	EVP & Chief Legal Officer	FTax Payment	−2,110 sh	$22.80	−$48.1K	52,126
2019-04-01	Keenova Therapeutics plcA Award	EVP & Chief Legal Officer	AAward	+17.1K sh	—	—	54,236
2019-04-01	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	EVP & Chief Legal Officer	AAward	+78.1K sh	—	—	78,129
2019-04-01	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	EVP & Chief Legal Officer	AAward	+78.1K sh	—	—	78,129
2019-02-01	Keenova Therapeutics plcF Tax Payment	EVP & Chief Legal Officer	FTax Payment	−1,248 sh	$22.34	−$27.9K	37,165
2018-04-02	Keenova Therapeutics plcA Award	EVP & Chief Legal Officer	AAward	+24.6K sh	—	—	38,413
2018-04-02	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	EVP & Chief Legal Officer	AAward	+129K sh	—	—	128,657
2018-02-01	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	EVP & Chief Legal Officer	AAward	+39.6K sh	—	—	39,581
2018-02-01	Keenova Therapeutics plcA Award	EVP & Chief Legal Officer	AAward	+13.8K sh	—	—	13,775
2018-01-03	Aceragen, Inc.Stock OptionA Award	Senior VP & General Counsel	AAward	+270K sh	$2.24	+$605K	270,000
2017-01-03	Aceragen, Inc.Stock OptionA Award	Senior VP & General Counsel	AAward	+185K sh	—	—	185,000
2016-05-12	Aceragen, Inc.P Purchase	Senior VP & General Counsel	PPurchase	+34.5K sh	$1.44	+$49.6K	34,450
2016-01-06	Aceragen, Inc.Stock OptionA Award	Senior VP & General Counsel	AAward	+185K sh	—	—	185,000
2015-06-29	Aceragen, Inc.Stock OptionA Award	Senior VP & General Counsel	AAward	+325K sh	—	—	325,000
2015-06-29	Aceragen, Inc.Stock OptionA Award	Senior VP & General Counsel	AAward	+275K sh	—	—	275,000
2014-11-18	HOLXHOLOGIC INC · Restricted Stock Unit Award (Right To Receive)M Exercise/Conversion	SVP, CAO, GC & Secretary	MExercise/Conversion	−3,350 sh	—	—	10,053
2014-11-18	HOLXHOLOGIC INCF Tax Payment	SVP, CAO, GC & Secretary	FTax Payment	−1,091 sh	$26.64	−$29.1K	14,725
2014-11-18	HOLXHOLOGIC INCM Exercise/Conversion	SVP, CAO, GC & Secretary	MExercise/Conversion	+3,350 sh	$26.64	+$89.2K	15,816
2014-11-14	HOLXHOLOGIC INCF Tax Payment	SVP, CAO, GC & Secretary	FTax Payment	−718 sh	$26.30	−$18.9K	12,466

Recent filings

Accepted (ET)
Mar 94/A
Casey Mark J0001104659-26-025365
SEC(opens sec.gov)
Mar 54
Casey Mark J0001104659-26-023715
SEC(opens sec.gov)
Mar 34
Casey Mark J0001104659-26-023069
SEC(opens sec.gov)
Dec 154
Casey Mark J0001104659-25-121103
SEC(opens sec.gov)
Mar 54
Casey Mark J0001593968-25-000306
SEC(opens sec.gov)
Mar 44
Casey Mark J0001593968-25-000288
SEC(opens sec.gov)
Dec 134
Casey Mark J0001593968-24-001472
SEC(opens sec.gov)

Companies

Address

21 FIRSTFIELD ROAD

GAITHERSBURG, MD, 20878